Previous Page
Transaction Reports Circassia Pharmaceuticals Plc Circassia to float on LSE
Circassia, a clinical-stage specialty biopharmaceutical company, has recently announced its intention to proceed with an initial public offering of its Shares to certain institutional and professional investors. Circassia intends to apply for admission of its Shares, issued and to be issued, to the premium listing segment of the Official List and to trading on the Main Market of the London Stock Exchange.
Circassia is focused on the development and commercialisation of a range of immunotherapy products for the treatment of allergies. The Company’s four lead product candidates have demonstrated clinical proof-of-concept in phase IIb studies, and the most advanced of these, Cat-SPIRE, is in a phase III registration study. These product
candidates were discovered using the Company’s innovative technology, ToleroMune®, which was initially developed at Imperial College, London, and was acquired by the Company, co-founded by Steven Harris (Chief Executive Officer) and Charles Swingland, in 2006.
PwC, who act as Circassia’s Reporting Accountants in a team led by Bowker Andrews (statutory audit partner) and Mark Hughes (Reporting Accountant), expressed “The Group is in an exciting stage of its lifecycle, driving its key product candidates through phase III trials, regulatory approval and commercialisation. The Group and its management team are expected to grow significantly over the next few years and have sought to embed procedures and controls to meet its obligations to operate as a public company in the UK.“
Pharmaceuticals plc to float on LSE
Circassia Joint book runners: Co-Managers:
Legal advisor to the company:
Auditor & reporting accountant:
PR Consultant:
Legal advisor to the book runner:
DAA
Clarion Hotel Dublin Airport sold to the DAA
Dalata, Ireland’s biggest hotel group, is taking over the operation of theClarion Hotel at Dublin Airport after it was bought by the Dublin Airport Authority (DAA) for more than €10m.
Dalata Hotel Group has a ten-year agreement in place to operate the 248-bedroom four-star hotel, making it the group’s 13th Maldron Hotel. The 150 staff at the hotel will become employees of Dalata.
Savills Hotels & Leisure Team successfully ran the sale process on behalf of KPMG and the National Asset Management Agency (NAMA). Led by Tom
Barrett, the property was marketed in H2 2013 and generated very strong domestic and international interest. After dealing with over 100 parties, a sale was completed with the DAA to purchase the hotel.
The property sold as a long leasehold interest with 55 years remaining on the lease and free of management and franchise agreements.
Savills Hotels & Leisure Team acted on almost 80% of Irish hotel sales which had a value of over €5m in 2013 and is the largest hotel property advisory team in Ireland.
Clarion Hotel
Dublin Airport sold to the DAA
Sales agent to Clarion Hotel Dublin: